Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)
Clinical trial NCT04125732 · COMPLETED
Trial details
- NCT number
- NCT04125732
- Sponsor
- XyloCor Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-24
- Primary completion
- 2023-01-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.